hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 12:10:50 - browse：629

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FTC falls short on scrutinizing hospital mergers, study says

explore

WSS

Dogs on Prozac: What pet anti

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Why rehabilitation engineers need to center patients in their research

Readout LOUD podcast: brain research, obesity drug sales, Novartis

H5N1 bird flu: what we're starting to learn about infection in cows

Diversity in clinical trials starts with building trust, experts say

knowledge

hotspot

hotspot

Psychedelics group wrestles with new pharma identity

Cancer researcher Catriona Jamieson is sending tumors into space

Duchenne breakthrough therapy leaves behind pioneering families

MultiPlan and major insurers sued for alleged medical price

Drug repurposing or repositioning? The language matters

Cue Health's Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Medical records are filled with copy

Use wet bulb globe temperature, not heat index, to protect workers

knowledge

Medicare says breakthrough device reimbursement rule to come by summer

What nurses really want: sufficient staffing for patient care

Use wet bulb globe temperature, not heat index, to protect workers

After gene therapy, two congenitally deaf children hear for the first time

Why rehabilitation engineers need to center patients in their research

Cancer researcher Catriona Jamieson is sending tumors into space

explore

explore

focus

Wikipedia